When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Thinly traded nano cap VistaGen Therapeutics (VTGN+5.3%) is up on double normal volume following its announcement of encouraging preclinical data on lead candidate AV-101 (4-chlorokynurenine), in development for major depressive disorder and neuropathic pain.
More news on: VistaGen Therapeutics, Inc., Healthcare stocks news, Stocks on the move,